Our mission is to provide cognitive assessment tools to a broad range of healthcare providers for the early detection of cognitive impairment. Early detection allows patients to address modifiable risk factors sooner, potentially changing the course of cognitive decline. It also allows healthcare providers to develop a plan with the patient and caregiver, so the patient can live their best life during their journey.

Cognivue’s^® proprietary FDA-cleared technology is based on adaptive psychophysics. The technology collects 130,000 data points, creating a unique patient experience customized to each patient’s individual visual and motor skills. This reliable test is validated against other recognized gold-standard cognitive assessment tools, while providing an experience custom to each patient. It is a self-administered computerized assessment which removes the bias that can be associated with more traditional cognitive assessment tools, standardizing your approach to testing.